MedPlus Health Services Ltd

Profit before tax (PBT) jumped 91.1% YoY to Rs 61.12 crore in the quarter ended 31st March 2025. Operating EBITDA stood at Rs 80.33 crore, registering the growth of 38.2% compared with Rs 58.13 crore posted in same quarter last year. Operating EBITDA margin improved to 5.3% in Q4 FY25 as against 3.9% in Q4 FY24. In Q4 FY25, the company added 100 stores. As on 31st March 2025, the total store count stood at 4,712. On full year basis, the company's consolidated net profit surged 129.6% to Rs 150.32 crore on 9.1% increase in revenue from operations to Rs 6,136.05 crore in FY25 over FY24. Meanwhile, the company's board approved the appointment of Subrahmanyam Sharma Tatapudi, as chief technology officer (CTO), (earlier serving as deputy chief technology officer), with effect from 27 May 2025. MedPlus Health Services (MedPlus) is an organized pharmacy retail company with both an online and offline presence. The company operates in retail and wholesale sales, import, distribution, manufacturing and contract manufacturing of private-label pharmaceuticals, wellness and FMCG products and full-fledged diagnostic centers. The counter hits 52-week high at Rs 1,052.05 in intraday today.Powered by Capital Market - Live

Net profit of Medplus Health Services rose 53.71% to Rs 51.34 crore in the quarter ended March 2025 as against Rs 33.40 crore during the previous quarter ended March 2024. Sales rose 1.28% to Rs 1509.61 crore in the quarter ended March 2025 as against Rs 1490.50 crore during the previous quarter ended March 2024. For the full year,net profit rose 129.60% to Rs 150.32 crore in the year ended March 2025 as against Rs 65.47 crore during the previous year ended March 2024. Sales rose 9.09% to Rs 6136.05 crore in the year ended March 2025 as against Rs 5624.86 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales1509.611490.50 1 6136.055624.86 9 OPM %9.037.10 -7.946.29 - PBDT125.3391.20 37 433.13297.66 46 PBT61.1231.99 91 183.2973.44 150 NP51.3433.40 54 150.3265.47 130 Powered by Capital Market - Live

Medplus Health Services will hold a meeting of the Board of Directors of the Company on 27 May 2025.Powered by Capital Market - Live

Net profit of Medplus Health Services rose 234.23% to Rs 45.89 crore in the quarter ended December 2024 as against Rs 13.73 crore during the previous quarter ended December 2023. Sales rose 8.32% to Rs 1561.45 crore in the quarter ended December 2024 as against Rs 1441.47 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1561.451441.47 8 OPM %8.496.37 - PBDT119.0777.07 54 PBT56.6019.96 184 NP45.8913.73 234 Powered by Capital Market - Live

Medplus Health Services will hold a meeting of the Board of Directors of the Company on 31 January 2025.Powered by Capital Market - Live

MedPlus Health Services has allotted 1,46,675 equity shares under ESOP on 18 December 2024. With this allotment, the paid up equity share capital has increased to 11,96,93,831 equity shares of each aggregating to Rs. 23,93,87,662. Powered by Capital Market - Live

Profit before tax soared 190.63% year on year (YoY) to Rs 47.78 in the quarter ended 30 September 2024. Operating EBITDA stood at 73.9 crore in September 2024 quarter, up 80.24% from Rs 41 crore reported in Q2 FY24. Operating EBITDA margin improved to 4.7% in Q2 FY25 as compared to 2.9% recorded in the corresponding period last year. Gross margin increased to 23.7% in second quarter of FY25 as against 21.6% posted in similar period previous fiscal. The pharmaco added 108 stores during the quarter taking the total to 4,552 stores, as on September 2024. Medplus Health Services is in the business of pathological laboratory testing and manufacturing, wholesale trading and contract manufacturing of pharma, fast-moving consumer goods and beauty products and rendering of management services to group companies and holds investments in subsidiary companies. Powered by Capital Market - Live

Net profit of Medplus Health Services rose 166.07% to Rs 38.74 crore in the quarter ended September 2024 as against Rs 14.56 crore during the previous quarter ended September 2023. Sales rose 11.90% to Rs 1576.17 crore in the quarter ended September 2024 as against Rs 1408.59 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1576.171408.59 12 OPM %7.906.04 - PBDT110.9271.92 54 PBT47.7816.44 191 NP38.7414.56 166 Powered by Capital Market - Live

Medplus Health Services will hold a meeting of the Board of Directors of the Company on 12 November 2024.Powered by Capital Market - Live

The equity benchmarks traded with major losses in morning trade. The Nifty traded below the 24,950 mark. PSU bank shares declined after advancing in the past consecutive trading sessions. At 10:30 ST, the barometer index, the S&P BSE Sensex, tumbled 658.83 points or 0.81% to 81,524.86. The Nifty 50 index slipped 205.10 points or 0.82% to 24,940. In the broader market, the S&P BSE Mid-Cap index fell 0.81% and the S&P BSE Small-Cap index shed 0.36%. The market breadth was weak. On the BSE, 1,304 shares rose and 2,344 shares fell. A total of 123 shares were unchanged. The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, rallied 6.56% to 14.90. New Listing: Shares of Baazar Style Retail were currently trading at Rs 405.40 at 10:13 IST on the BSE, representing a premium of 4.22% as compared with the issue price of Rs 389. The scrip was listed at Rs 389, matching the issue price. So far, the stock has hit a high of 416.95 and a low of 378.15. On the BSE, over 9.36 lakh shares of the company were traded in the counter so far. Buzzing Index: The Nifty PSU bank index declined 2.11% to 6,755.30. The index rose 0.32% in the past consecutive trading sessions. State Bank of India (down 2.74%), Canara Bank (down 2.71%), Indian Overseas Bank (down 2.65%), Punjab & Sind Bank (down 2.12%), Punjab National Bank (down 2.04%), UCO Bank (down 1.91%), Bank of Maharashtra (down 1.76%), Central Bank of India (down 1.74%), Bank of Baroda (down 1.58%) and Indian Bank (down 1.39%) declined. Stocks in Spotlight: Medplus Health Services fell 0.23%. The company's subsidiary, Optival Health Solutions has received two suspension orders for drug licenses for stores situated in Bangalore, Karnataka. Aptus Value Housing Finance declined 1.43%. The company's board approved the alloment of 10,000 non convertible debentures (NCDs) of Rs 1 lakh each amounting to Rs 100 crore through private placement. Camlin Fine Sciences fell 1.75%. The company's board will meet on 10 September 2024, to consider raising funds via right issue of equity shares.Powered by Capital Market - Live